- CEO
- Hong-Sik Jang
- Full Time Employees
- 96
- Sector
- Distribution services
- Industry
- Electronics distributors
- Address
- Seongnam-si South Korea
- IPO Date
- Jul 18, 1997
- Business
- Wonik Corporation is a South Korea-based diversified company engaged primarily in the distribution of advanced medical devices and industrial materials, the manufacture of electronic components, and the development of derma-cosmetics. Founded in 1983 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company serves as the foundational enterprise of the Wonik Group and is publicly listed on the KOSDAQ market under the ticker symbol 032940.
The company organizes its business activities into three core operating segments: Medical and Trading, Electronic Components, and Leisure. Through its Medical and Trading division, which constitutes the majority of corporate revenue, Wonik Corporation imports, markets, and distributes specialized healthcare equipment and industrial raw materials. Its healthcare portfolio comprises aesthetic and surgical laser systems; urological, dermatological, and endoscopic medical devices; diagnostic instruments; and clinical consumables supplied to domestic hospitals, clinics, and research institutions through long-standing distribution partnerships with international equipment manufacturers. Through its majority-owned subsidiary CMS Lab Co., Ltd., the company develops and markets functional derma-cosmetic skincare products under established brand names including Cell Fusion C, Cell Fusion C Expert, and Suiskin, targeting both professional clinical channels and global retail consumers. In industrial trading, the company supplies high-purity fused quartz raw materials, ingots, and tubing utilized in semiconductor and display fabrication, alongside specialty industrial lighting equipment, ultraviolet lamps, and optical components.
Through its Electronic Components division, Wonik Corporation designs and manufactures custom electronic solutions, including thick-film hybrid integrated circuits (HICs); ceramic substrates; automotive and industrial pressure sensors; ultrasonic transducers; and specialized power control modules for consumer electronics, automotive assemblies, and industrial automation systems. The company also operates a leisure division that manages specialized sports and recreational facilities.
Geographically, Wonik Corporation operates primarily across South Korea while maintaining export and distribution networks spanning mainland China, Japan, Southeast Asia, Europe, and the Americas for its electronic components, quartz materials, and derma-cosmetic skincare lines.
In recent strategic developments, Wonik Corporation has executed operational and capital restructuring initiatives to enhance shareholder value and accelerate high-margin business growth. In July 2025, the company implemented a formal treasury share retirement program to optimize its capital structure and enhance equity returns. Operationally, the company has expanded the international distribution footprint of its derma-cosmetic business, scaling the presence of the Cell Fusion C brand across major East Asian and Western e-commerce and retail channels while launching upgraded clinical sun-care and barrier-repair formulations. Concurrently, Wonik Corporation has broadened its medical device portfolio by securing extended distribution agreements for next-generation minimally invasive surgical and dermatological laser systems, while streamlining internal manufacturing processes in its electronic sensor and hybrid IC units to meet growing demand from industrial automation and automotive electronics clients.